Randomized clinical trial of adjuvant chemotherapy with docetaxel and carboplatin for completely resected stage IB to IIIA non-small cell lung cancer (NSCLC): Preliminary result of Chinese society of lung cancer (CSLC) protocol 0201

被引：0
|
作者：
Yang, X
Wu, Y
Chen, G
Xu, L
Gu, L
Tang, P
Zhu, Y
Xiao, P
Tang, J
Xie, L
机构：
[1] Guangdong Provincial Peoples Hosp, Ctr Canc, Guangzhou, Peoples R China
[2] Guangdong Provincial Peoples Hosp, Lung Canc Res Inst, Guangzhou, Peoples R China
[3] Zhongshan Univ, 3rd Hosp, Guangzhou, Guangdong, Peoples R China
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)80435-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [21] Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): Report of cancer and leukemia group B (CALGB) protocol 9633.
    Strauss, GM
    Herndon, J
    Maddaus, MA
    Johnstone, DW
    Johnson, EA
    Watson, DM
    Sugarbaker, DJ
    Schilsky, RL
    Green, MR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 621S - 621S
  • [22] A pilot study of adjuvant chemotherapy with carboplatin and oral S-1 for patients with completely resected stage II to IIIA non-small cell lung cancer
    Tanaka, Hisashi
    Tabe, Chiori
    Okumura, Fumihiko
    Shiratori, Toshihiro
    Ishioka, Yoshiko
    Itoga, Masamichi
    Taima, Kageaki
    Morimoto, Takeshi
    Kimura, Daisuke
    Tsushima, Takao
    Tasaka, Sadatomo
    THORACIC CANCER, 2020, 11 (06) : 1633 - 1638
  • [23] MARKERS OF PROGNOSIS IN RESECTED STAGE IB NON-SMALL CELL LUNG CANCER (NSCLC)
    Yip, Po Yee
    Cooper, Wendy
    Mahar, Annabelle
    Kench, James
    Kohonen-Corish, Maija R. J.
    Chatfield, Mark
    Boulghourjian, Alice
    Kennedy, Catherine W.
    Mccaughan, Brian
    Boyer, Michael
    Horvath, Lisa
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S499 - S499
  • [24] Review of practice patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer (NSCLC)
    Visbal, A
    Kassam, F
    Johnston, M
    Feld, R
    Shepherd, F
    Darling, G
    Keshavjee, S
    Pierre, A
    Waddell, T
    Leighl, N
    LUNG CANCER, 2005, 49 : S97 - S97
  • [25] Adjuvant chemotherapy for completely resected non-small cell lung cancer: A systematic review
    Alam, Naveed
    Darling, Gail
    Evans, William K.
    Mackay, Jean A.
    Shepherd, Frances A.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 58 (02) : 146 - 155
  • [26] Randomised study of adjuvant chemotherapy for completely resected p-stage I-IIIA non-small cell lung cancer
    Nakagawa, K.
    Tada, H.
    Akashi, A.
    Yasumitsu, T.
    Iuchi, K.
    Taki, T.
    Kodama, K.
    BRITISH JOURNAL OF CANCER, 2006, 95 (07) : 817 - 821
  • [27] Adjuvant Chemotherapy for Patients with Stage IB Non-Small Cell Lung Cancer
    Wang, Jia
    Yue, Yang
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S641 - S642
  • [28] The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected non-small cell lung cancer
    Stinchcombe, Thomas E.
    Harper, Harry D.
    Hensing, Thomas A.
    Moore, Dominic T.
    Crane, Jeffery M.
    Atkins, James N.
    Willard, Ellen M.
    Detterbeck, Frank C.
    Socinski, Mark A.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (02) : 145 - 151
  • [29] Adjuvant treatment of completely resected stage IB-IIIA non-small-cell lung cancer - a retrospective study with cisplatin or carboplatin and oral vinorelbine
    Engel-Riedel, W.
    Alten, N.
    Bachinger, A.
    Magnet, F. S.
    Ludwig, C.
    Stoelben, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S805 - S805
  • [30] Adjuvant chemotherapy for resected non-small cell lung cancer
    Booth, Christopher M.
    Shepherd, Frances A.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (02) : 180 - 187
12345